Donafinib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Donafinib, covering 2026-02-17 to 2026-02-17. Get the full timeline:
Most recent: Clinical Trial Update: Study on the Safety and Efficacy of Donafinib Combined With Anti-PD-1 Antibody as Adjuvant Therapy for HCC Patients [Phase 1]